Search research articles
Contact Us
Filters
Showing results (1-10 of 174) with videos related to
Page
of 18
Sort By:
Rheumatic Diseases Clinics of North America
|
April 7, 2007
Current treatment for psoriatic arthritis and other spondyloarthritides
Philip Mease
Bulletin of the NYU Hospital for Joint Diseases
|
November 24, 2006
Psoriatic arthritis update
Philip Mease
Clinical and Experimental Rheumatology
|
October 17, 2013
Is reduction or discontinuation of therapy an acceptable possibility in psoriatic arthritis?
Philip Mease
Arthritis & Rheumatology (Hoboken, N.J.)
|
January 3, 2019
Ustekinumab Fails to Show Efficacy in a Phase III Axial Spondyloarthritis Program: The Importance of Negative Results
Philip Mease
Clinical and Experimental Rheumatology
|
October 17, 2015
A short history of biological therapy for psoriatic arthritis
Philip Mease
Current Rheumatology Reports
|
June 8, 2019
Emerging Immunomodulatory Therapies and New Treatment Paradigms for Axial Spondyloarthritis
Philip Mease
The Journal of Rheumatology. Supplement
|
August 4, 2005
Fibromyalgia syndrome: review of clinical presentation, pathogenesis, outcome measures, and treatment
Philip Mease
Current Opinion in Rheumatology
|
March 16, 2013
Psoriatic arthritis and spondyloarthritis assessment and management update
Philip Mease
Bulletin of the Hospital for Joint Disease (2013)
|
November 14, 2013
Methotrexate in psoriatic arthritis
Philip Mease
Lancet (London, England)
|
May 29, 2017
New pathways of treatment for psoriatic arthritis
Philip Mease
Page
of 18
Search research articles
Search
Showing results (1-10 of 174) with videos related to
Sort By:
Page
of 18
Rheumatic Diseases Clinics of North America
|
April 7, 2007
Current treatment for psoriatic arthritis and other spondyloarthritides
Philip Mease
Bulletin of the NYU Hospital for Joint Diseases
|
November 24, 2006
Psoriatic arthritis update
Philip Mease
Clinical and Experimental Rheumatology
|
October 17, 2013
Is reduction or discontinuation of therapy an acceptable possibility in psoriatic arthritis?
Philip Mease
Arthritis & Rheumatology (Hoboken, N.J.)
|
January 3, 2019
Ustekinumab Fails to Show Efficacy in a Phase III Axial Spondyloarthritis Program: The Importance of Negative Results
Philip Mease
Clinical and Experimental Rheumatology
|
October 17, 2015
A short history of biological therapy for psoriatic arthritis
Philip Mease
Current Rheumatology Reports
|
June 8, 2019
Emerging Immunomodulatory Therapies and New Treatment Paradigms for Axial Spondyloarthritis
Philip Mease
The Journal of Rheumatology. Supplement
|
August 4, 2005
Fibromyalgia syndrome: review of clinical presentation, pathogenesis, outcome measures, and treatment
Philip Mease
Current Opinion in Rheumatology
|
March 16, 2013
Psoriatic arthritis and spondyloarthritis assessment and management update
Philip Mease
Bulletin of the Hospital for Joint Disease (2013)
|
November 14, 2013
Methotrexate in psoriatic arthritis
Philip Mease
Lancet (London, England)
|
May 29, 2017
New pathways of treatment for psoriatic arthritis
Philip Mease
Page
of 18